IP Library › Granted Patent US 8,725,225
Granted Patent B2
US 8,725,225 · App. 11/836,737 · Granted May 13, 2014

Intraoperative imaging of renal cortical tumors and cysts

Inventors: Dragan Golijanin (Rochester, NY); Edward M. Messing (Rochester, NY)
Assignee: University of Rochester
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,725,225
App. No.
11/836,737
Granted
May 13, 2014
Kind
B2
Abstract

The invention provides methods for visualizing renal tumors and for staging cysts during an operation by use of a fluorescent dye.

Claims (40)

1. A method of detecting the presence or absence of a tumor in an area of a kidney in a subject during a surgical operation, comprising:

a) intravenously administering to said subject indocyanine green (ICG) which fluoresces at a near infrared emission wavelength when said dye is contacted with a near infrared excitation wavelength;

b) illuminating said kidney during said operation with said near infrared excitation wavelength such that the ICG in said kidney fluoresces; and,

c) detecting the presence or absence of fluorescence of the ICG in said kidney during said operation, using a video camera with optical filtering to block ambient and laser light, wherein detecting absence of fluorescence in said area indicates the presence of a tumor in said area, and detecting the presence of fluorescence in said area indicates the absence of a tumor in said area.

2. A method of claim 1 , wherein there are a plurality of tumors in said kidney.

3. A method of claim 1 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

4. A method of claim 1 , wherein said tumor is visualized on an image display.

5. A method of claim 1 , wherein said exposing of said kidney to said illumination comprising said excitation wavelength is by a laproscopic instrument.

6. A method of claim 1 , wherein the subject is a human.

7. A method of claim 1 , wherein said dye is administered during said surgical operation.

8. A method of claim 1 , wherein said dye is administered within 1 hour before said surgical operation.

9. A method of claim 8 , wherein said dye is administered within about ½ hour before said surgical operation.

10. A method of claim 8 , wherein said dye is administered within about ½ hour before said surgical operation.

11. A method of visualizing a tumor in a kidney in a subject during a surgical operation, comprising:

a) intravenously administering to said subject indocyanine green (ICG) which fluoresces at a near infrared emission wavelength when said dye is contacted with a near infrared excitation wavelength;

b) illuminating said kidney during said operation with said near infrared excitation wavelength such that the ICG in said kidney fluoresces; and,

c) visualizing the presence or absence of fluorescence of the ICG in said kidney during said operation, using a video camera with optical filtering to block ambient and laser light, wherein visualizing an area of said kidney in which fluorescence is absent is a visualization of said tumor.

12. A method of claim 11 , wherein there are a plurality of tumors in said kidney.

13. A method of claim 11 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

14. A method of claim 11 , wherein said tumor is visualized on an image display.

15. A method of claim 11 , wherein said exposing of said kidney to said illumination comprising said excitation wavelength is by a laproscopic instrument.

16. A method of claim 11 , wherein the subject is a human.

17. A method of claim 11 , wherein said dye is administered during said surgical operation.

18. A method of claim 11 , wherein said dye is administered within 1 hour before said surgical operation.

19. A method of visualizing a tumor margin in tissue excised from a kidney during a surgical operation, comprising:

a) intravenously administering to said subject indocyanine green (ICG) which fluoresces at a near infrared emission wavelength when said dye is contacted with a near infrared excitation wavelength,

b) excising some or all of a tumor and surrounding tissue from said kidney during said operation,

c) illuminating said kidney during said operation with said near infrared excitation wavelength such that the ICG in said kidney fluoresces; and

d) visualizing the presence or absence of fluorescence of the ICG, using a video camera with optical filtering to block ambient and laser light, wherein visualizing fluorescence around said some or all of said tumor indicates the presence of a tumor margin, and an absence of said fluorescence around some or all of said tumor indicates the absence of a tumor margin.

20. A method of claim 19 , wherein there are a plurality of tumors in said kidney.

21. A method of claim 19 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

22. A method of claim 19 , wherein said tumor and any surrounding tissue is visualized on an image display.

23. A method of claim 19 , wherein the subject is a human.

24. A method of determining during a surgical operation whether a cyst in a kidney in a subject is benign or contains malignant cells, comprising:

a) intravenously administering to said subject a dye indocyanine green (ICG) which fluoresces at an a near infrared emission wavelength when said dye ICG is contacted with an a near infrared excitation wavelength;

b) illuminating said cyst during said operation with said near infrared excitation wavelength under conditions such that the ICG in said cyst fluoresces; and,

c) comparing the fluorescence of said dye the ICG in said cyst during said operation to the fluorescence of surrounding kidney tissue, using a video camera with optical filtering to block ambient and laser light, wherein bright fluorescence in said cyst compared to said surrounding kidney tissue indicates that the cyst is benign and low or no fluorescence in said cyst compared to said surrounding kidney tissue indicates that the cyst contains malignant cells.

25. A method of claim 24 , wherein said dye is administered locally into the renal artery, the superior segmental artery, anterior superior segmental artery, anterior inferior segmental artery, inferior segmental artery, an arcuate artery, or an interlobular artery.

26. A method of claim 24 , wherein said cyst is visualized on an image display.

27. A method of claim 24 , wherein said exposing of said cyst to said illumination comprising said excitation wavelength is by a laproscopic instrument.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2009
From: GOLIJANIN, DRAGAN; MESSING, EDWARD M.
To: UNIVERSITY OF ROCHESTER
Reel/Frame 022453/0900 →
Continuity (2)
Provisional Application 60837414 · Aug 10, 2006
Related Publication 20080161662A1 · Jul 3, 2008